Oral oxymorphone (Opana).
D000284:Administration, Oral; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001682:Biological Availability; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D017116:Low Back Pain / Q000188:drug therapy; D009369:Neoplasms / Q000150:complications; D009293:Opioid-Related Disorders; D010003:Osteoarthritis / Q000150:complications; D010111:Oxymorphone / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology*; D010149:Postoperative Pain / Q000188:drug therapy
D000701:Analgesics, Opioid; D003692:Delayed-Action Preparations; D010111:Oxymorphone